261 related articles for article (PubMed ID: 25040039)
1. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
[TBL] [Abstract][Full Text] [Related]
2. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Chernoff D; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1519-29. PubMed ID: 23121409
[TBL] [Abstract][Full Text] [Related]
4. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
[TBL] [Abstract][Full Text] [Related]
5. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
6. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
[TBL] [Abstract][Full Text] [Related]
7. A dual CysLT
Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
9. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of allergen-induced asthmatic response in smokers and non-smokers: effects of inhaled corticosteroids.
Cahn A; Boyce M; Mistry S; Musani N; Rambaran C; Storey J; Ventresca P; Michel O
Clin Exp Allergy; 2015 Oct; 45(10):1531-41. PubMed ID: 26251958
[TBL] [Abstract][Full Text] [Related]
12. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
[TBL] [Abstract][Full Text] [Related]
13. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
14. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
15. The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma.
Leaker BR; Singh D; Ali FY; Barnes PJ; O'Connor B
BMC Pulm Med; 2014 Oct; 14():166. PubMed ID: 25351474
[TBL] [Abstract][Full Text] [Related]
16. The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma.
Kent SE; Boyce M; Diamant Z; Singh D; O'Connor BJ; Saggu PS; Norris V
Clin Exp Allergy; 2013 Feb; 43(2):177-86. PubMed ID: 23331559
[TBL] [Abstract][Full Text] [Related]
17. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
[TBL] [Abstract][Full Text] [Related]
18. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens.
Boulet LP; Gauvreau G; Boulay ME; O'Byrne PM; Cockcroft DW
Clin Exp Allergy; 2015 Nov; 45(11):1647-53. PubMed ID: 26115509
[TBL] [Abstract][Full Text] [Related]
19. The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.
Gauvreau GM; FitzGerald JM; Boulet LP; Watson RM; Hui L; Villineuve H; Scime TX; Schlatman AR; Obminski C; Kum J; Boehme S; Ly TW; Bacon KB; O'Byrne PM
Clin Exp Allergy; 2018 Apr; 48(4):445-451. PubMed ID: 29423947
[TBL] [Abstract][Full Text] [Related]
20. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C
Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
